Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dalteparin prophylaxis and implantation in assisted reproduction
2011-002219-28Phase 3Active
- Sponsor
- Azienda Ospedaliero-Universitaria di Padova
- Start
- Mar 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial of dalteparin in female infertility, implantation failure, Recurrent Implantation Failure (RIF) and 1 more (2 arms), sponsored by Azienda Ospedaliero-Universitaria di Padova. Primary endpoint: Failure rate of the first implantation. Started Mar 2012; status: active.
02
Drugs
dalteparin
03
Conditions
female infertilityimplantation failureRecurrent Implantation Failure (RIF)Hypercoagulability
Beyond the preview
Go deeper on 2011-002219-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002219-28.